Faeth Therapeutics(FTH)
$10.65-2.70 (-20.22%)
FTH
Faeth Therapeutics financials statements
$10.65
At close:-2.70 (-20.22%)
Want to see FTH full AI Analyst Report?
Faeth Therapeutics (FTH) Income Statement
272 Followers
Faeth Therapeutics Income Statement
Last quarter (Q3 2026), Faeth Therapeutics's total revenue was $0.00, an increase of 100.00% from the same quarter last year. In Q3, Faeth Therapeutics's net income was $-20.40M. See Faeth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -551.00K | $ -571.00K | $ -1.81M | $ -685.00K | |
| $ 22.29M | $ 31.11M | $ 36.49M | $ 47.31M | $ 36.80M | |
| Depreciation and Amortization | $ 139.00K | $ 1.32M | $ 1.35M | $ 1.35M | $ 685.00K |
| $ -20.91M | $ -28.75M | $ -35.61M | $ -47.02M | $ -35.44M | |
| $ -22.29M | $ -31.66M | $ -37.06M | $ -49.12M | $ -37.48M | |
| $ 1.20M | $ 1.51M | $ 2.96M | $ 532.00K | $ 688.00K | |
| $ -21.09M | $ -30.16M | $ -34.10M | $ -48.59M | $ -36.79M | |
| $ -21.09M | $ -30.16M | $ -34.10M | $ -48.59M | $ -36.79M | |
| Per Share Metrics | |||||
| Basic EPS | $ -16.72 | $ -24.01 | $ -24.40 | $ -31.65 | $ -26.56 |
| Diluted EPS | $ -16.72 | $ -24.01 | $ -24.40 | $ -31.65 | $ -26.56 |
| Weighted Average Shares Outstanding | 1.26M | 1.26M | 1.40M | 1.54M | 1.39M |
| Weighted Average Shares Outstanding (Diluted) | 1.26M | 1.26M | 1.40M | 1.54M | 1.39M |
Currency in USD
